Viatris Announces Regulatory Milestones Across its Drug Pipeline for 2025 Viatris Inc. reveals significant regulatory achievements, including FDA approvals and new applications for several important medications, underscoring its commitment to healthcare innovation.

Viatris Announces Regulatory Milestones Across its Drug Pipeline for 2025 #United_States #Pittsburgh #FDA_Approvals #Viatris #drug_pipeline

TYK2 Inhibitors Market Expected to See Robust Growth by 2034 with Expanding Drug Pipeline The TYK2 inhibitors market is set for tremendous growth by 2034, mainly due to the rising prevalence of autoimmune diseases and a strengthening drug pipeline.

TYK2 Inhibitors Market Expected to See Robust Growth by 2034 with Expanding Drug Pipeline #None #Autoimmune_Diseases #TYK2_inhibitors #drug_pipeline